Cargando…
Patient-derived xenograft models—the future of personalised cancer treatment
For many tumours there is a lack of randomised data from which we can guide systemic treatments. Although gene expression profiling along with proteomics has led to advances in diagnosis, classification and prognosis, our ability to target many cancers has been further limited due to a lack of thera...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054515/ https://www.ncbi.nlm.nih.gov/pubmed/31919403 http://dx.doi.org/10.1038/s41416-019-0678-0 |